Research graph
References from Continuous Glucose Monitoring and Long-Term Glycemic and Kidney Outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
International consensus on use of continuous glucose monitoring.
10.2337/dc17-1600 · 2017 · External reference
Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve.
10.2337/ds20-0090 · 2021 · External reference
Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial.
10.7326/m16-2855 · 2017 · External reference
Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial.
10.1001/jama.2021.7444 · 2021 · External reference
IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): a randomized controlled trial.
10.1111/dom.14949 · 2023 · External reference
Continuous glucose monitor use prevents glycemic deterioration in insulin-treated patients with type 2 diabetes.
10.1089/dia.2021.0450 · 2022 · External reference
Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes.
10.1001/jama.2021.6530 · 2021 · External reference
Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register.
10.1177/14791641211067418 · 2023 · External reference
Flash CGM is associated with reduced diabetes events and hospitalizations in insulin-treated type 2 diabetes.
10.1210/jendso/bvab013 · 2021 · External reference
Using big data to emulate a target trial when a randomized trial is not available.
10.1093/aje/kwv254 · 2016 · External reference
Target trial emulation: a framework for causal inference from observational data.
10.1001/jama.2022.21383 · 2022 · External reference
The target trial framework for causal inference from observational data: why and when is it helpful?
10.7326/annals-24-01871 · 2025 · External reference
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
10.1136/bmj.39335.541782.ad · 2007 · External reference
Transparent Reporting of Observational Studies Emulating a Target Trial: The TARGET Statement.
10.1001/jama.2025.13350 · 2025 · External reference
Causal inference about the effects of interventions from observational studies in medical journals.
10.1001/jama.2024.7741 · 2024 · External reference
Cohort profile: The Diabetes Study of Northern California (DISTANCE)–objectives and design of a survey follow-up study of social health disparities in a managed care population.
10.1093/ije/dyn040 · 2009 · External reference
Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: consequences and statistical approaches.
10.1002/pds.5338 · 2021 · External reference
Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis.
10.7326/m20-0529 · 2020 · External reference
Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant.
10.1001/jamanetworkopen.2020.34004 · 2021 · External reference
Overall uptake and racial, ethnic, and socioeconomic disparities in the use of continuous glucose monitoring devices among insulin-treated older adults with type 2 diabetes.
10.2337/dca25-0006 · 2025 · External reference
Marginal structural models and causal inference in epidemiology.
10.1097/00001648-200009000-00011 · 2000 · External reference
Association, causation, and marginal structural models.
10.1023/a:1005285815569 · 1999 · External reference
A structural approach to selection bias.
10.1097/01.ede.0000135174.63482.43 · 2004 · External reference
Association between adherence, A1C improvement, and type of continuous glucose monitoring system in people with type 1 diabetes or type 2 diabetes treated with intensive insulin therapy.
10.1007/s13300-023-01529-8 · 2024 · External reference
Super learner.
10.2202/1544-6115.1309 · 2007 · External reference
Regression shrinkage and selection via the Lasso.
10.1111/j.2517-6161.1996.tb02080.x · 1996 · External reference
Data-adaptive selection of the propensity score truncation level for inverse-probability-weighted and targeted maximum likelihood estimators of marginal point treatment effects.
10.1093/aje/kwac087 · 2022 · External reference
The influence curve and its role in robust estimation.
10.1080/01621459.1974.10482962 · 1974 · External reference
Effectiveness of continuous glucose monitoring on metrics of glycemic control in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
10.1210/clinem/dgad652 · 2024 · External reference
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.
10.1136/bmjdrc-2015-000154 · 2016 · External reference
Perspectives on chronic kidney disease with type 2 diabetes and risk management: practical viewpoints and a paradigm shift using a pillar approach.
10.2337/cd22-0110 · 2023 · External reference
Type 2 diabetes and chronic kidney disease: an opportunity for pharmacists to improve outcomes.
10.3390/jcm13051367 · 2024 · External reference
Diabetes and chronic kidney disease.
10.1001/jama.2024.24671 · 2025 · External reference
Improved time in range over 1 year is associated with reduced albuminuria in individuals with sensor-augmented insulin pump-treated type 1 diabetes.
10.2337/dc20-0909 · 2020 · External reference
Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes.
10.1089/dia.2019.0499 · 2020 · External reference
Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes.
10.1186/s13098-023-01071-4 · 2023 · External reference
Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.
10.1007/s00592-023-02214-9 · 2024 · External reference
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
10.1001/jama.290.16.2159 · 2003 · External reference
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
10.1001/archinternmed.2011.16 · 2011 · External reference
Dysglycemic events after initiation of intermittently scanned continuous glucose monitoring in patients with insulin-treated type 2 diabetes.
10.1089/dia.2025.0021 · 2025 · External reference
10.1007/978-1-4419-9782-1
10.1007/978-1-4419-9782-1 · 2011 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2016 · External reference
Unresolved reference
2016 · External reference
Unresolved reference
External reference
